What is Chemotherapy Drugs Market?
According to Centres for Disease Contro and Prevention (CDC), the U.S., each year about 650,000 cancer patients receive chemotherapy in an outpatient oncology clinic in the United States. It is estimated that Chemotherapy is one of the most common treatments for cancer that uses powerful chemicals to kill fast-growing cancerous cells in the patient's body. Chemotherapy drugs are used alone or in combination with other drugs for the treatment of a wide variety of cancers. These drugs are very different in their chemical composition that work differently. These drugs affect cancerous cells as well as normal cells. The affected normal cells recover from the effects of chemo over time, but cancer cells do not recover from the effects of chemo.
The market study is being classified by Type (Alkylating Agents, Antitumor Antibiotics, Plant Alkaloids, Antimetabolites, Topoisomerase Inhibitors and Miscellaneous Antineoplastic) and major geographies with country level break-up.
Johnson & Johnson Services Inc (United States), GlaxoSmithKline PLC (United Kingdom), Eli Lilly and Company (United States), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Pfizer Inc. (United States), Merck & Co. Inc. (United States), Sanofi S.A. (France), Celgene Corporation (United States) and Bristol-Myers Squibb Company (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Takeda Pharmaceutical Company Limited (Japan), Tesaro, Inc. (United States) and Clovis Oncology, Inc. (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Chemotherapy Drugs market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Chemotherapy Drugs market by Type, Application and Region.
On the basis of geography, the market of Chemotherapy Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Number of Chemotherapy Treatments
- Increasing Prevalence of Various Cancers among People
- High Demand for Advanced Cancer Drugs
- Increasing Research and Development Activities
- Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical and Breast Cancer Treatment
- Side Effects of the Chemotherapy Drugs on the Patient
- No Complete Cure Treatment Availability for Some Caners such as Blood Caners
- Growth in the Healthcare Industry Worldwide
- Rise in the Healthcare Infrastructure in Developing Regions
- Increasing Number of Online Pharmacies
- Stringent Government Rules and Regulations for New Drug Approval
Market Leaders and some development strategies
In December 2019, Johnson & Johnson has announced the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company specializing in the development of a novel drug delivery technology for the treatment of bladder diseases including cancer. The company's lead clinical-stage product, TAR-200, uses the proprietary TARIS System, which features a silicone-based drug delivery device that allows for the continuous release of medication into the bladder.
Key Target AudienceChemotherapy Drugs Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase